|
RB1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.943800E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.317000E-01 |
| Normal-vs-Stage2 |
3.474200E-01 |
| Normal-vs-Stage3 |
1.780210E-01 |
| Normal-vs-Stage4 |
1.142190E-01 |
| Stage1-vs-Stage2 |
2.082800E-01 |
| Stage1-vs-Stage3 |
8.159700E-02 |
| Stage1-vs-Stage4 |
8.840300E-02 |
| Stage2-vs-Stage3 |
2.818100E-02 |
| Stage2-vs-Stage4 |
2.853600E-02 |
| Stage3-vs-Stage4 |
7.381200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.004000E-01 |
| Normal-vs-AfricanAmerican |
6.142200E-01 |
| Normal-vs-Asian |
7.525600E-02 |
| Caucasian-vs-AfricanAmerican |
3.626600E-01 |
| Caucasian-vs-Asian |
1.470960E-01 |
| AfricanAmerican-vs-Asian |
1.128780E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.073800E-01 |
| Normal-vs-Female |
7.314200E-01 |
| Male-vs-Female |
8.041600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.584000E-01 |
| Normal-vs-Age(41-60Yrs) |
3.169800E-01 |
| Normal-vs-Age(61-80Yrs) |
8.613800E-01 |
| Normal-vs-Age(81-100Yrs) |
5.582200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.018970E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.711400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.472200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.351200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.354800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.659000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.050400E-01 |
| Classical-VS-Follicular |
2.116800E-01 |
| Classical-VS-Other |
3.409000E-01 |
| Classical-VS-Normal |
7.653600E-01 |
| Tall-VS-Follicular |
7.624400E-02 |
| Tall-VS-Other |
6.586200E-01 |
| Tall-VS-Normal |
2.405800E-01 |
| Follicular-VS-Other |
2.419200E-01 |
| Follicular-VS-Normal |
4.554000E-01 |
| Other-VS-Normal |
2.397600E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.307000E-01 |
| Normal-vs-N1 |
6.294500E-02 |
| N0-vs-N1 |
5.197600E-02 |
|
|
